MENU
+Compare
CTKB
Stock ticker: NASDAQ
AS OF
Jul 18, 03:50 PM (EDT)
Price
$3.13
Change
-$0.17 (-5.15%)
Capitalization
876.52M

CTKB Cytek Biosciences Forecast, Technical & Fundamental Analysis

Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches... Show more

CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for CTKB with price predictions
Jul 17, 2025

Momentum Indicator for CTKB turns negative, indicating new downward trend

CTKB saw its Momentum Indicator move below the 0 level on July 11, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 56 similar instances where the indicator turned negative. In of the 56 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for CTKB turned negative on July 14, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 35 similar instances when the indicator turned negative. In of the 35 cases the stock turned lower in the days that followed. This puts the odds of success at .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CTKB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

CTKB moved above its 50-day moving average on June 25, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for CTKB crossed bullishly above the 50-day moving average on June 27, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 12 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CTKB advanced for three days, in of 218 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 102 cases where CTKB Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. CTKB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.230) is normal, around the industry mean (24.469). CTKB has a moderately high P/E Ratio (370.370) as compared to the industry average of (77.706). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (4.697) is also within normal values, averaging (42.883).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CTKB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
CTKB
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

CTKB is expected to report earnings to fall 57.78% to -3 cents per share on August 12

Cytek Biosciences CTKB Stock Earnings Reports
Q2'25
Est.
$-0.04
Q1'25
Missed
by $0.07
Q4'24
Beat
by $0.01
Q3'24
Est.
$0.01
Q2'24
Missed
by $0.08
The last earnings report on May 08 showed earnings per share of -9 cents, missing the estimate of -1 cents. With 181.27K shares outstanding, the current market capitalization sits at 876.52M.
A.I. Advisor
published General Information

General Information

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
47215 Lakeview Boulevard
Phone
+1 877 922-9835
Employees
676
Web
https://www.cytekbio.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MASCX13.000.03
+0.27%
BlackRock Sustainable Advantage GlEqInvA
DBICX10.21N/A
N/A
DWS Global Macro C
AWTIX20.34N/A
N/A
Virtus Duff & Phelps Water Inst
JEPAX14.06N/A
N/A
JPMorgan Equity Premium Income A
MSCQX11.22N/A
N/A
Mercer US Small/Mid Cap Equity I

CTKB and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CTKB has been loosely correlated with GMED. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if CTKB jumps, then GMED could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CTKB
1D Price
Change %
CTKB100%
+1.85%
GMED - CTKB
48%
Loosely correlated
+1.66%
CRL - CTKB
45%
Loosely correlated
+1.14%
TMCI - CTKB
44%
Loosely correlated
-1.03%
BRKR - CTKB
43%
Loosely correlated
+1.56%
IQV - CTKB
43%
Loosely correlated
+2.91%
More